Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
about
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.Enhancement of soluble CD28 levels in the serum of Graves' diseaseSheddomeDB: the ectodomain shedding database for membrane-bound shed markers.CD28-B7 interaction modulates short- and long-lived plasma cell function.Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus.New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland.CD28 proximal promoter polymorphisms in systemic lupus erythematosus susceptibility.Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus.MicroRNA array analysis of microRNAs related to systemic scleroderma.Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old populationHuman Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationThe soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysmAberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosusIncreased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthmaElevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma
P2860
Q34897654-0E750D27-B8A0-456D-BF56-D6B53FAA3AA5Q35619699-70FB1D68-B3BC-4AB6-9287-62DF406AC811Q35631893-B9060A16-0AD3-407D-8FE7-9150E686B54EQ36329547-91C6B636-4678-4547-A025-46CF72C45A57Q36849492-35A6FCE9-AA8B-4DF0-8DFB-1F8B6DBACB4DQ36984486-82342BEC-7F85-45DA-8012-D4126EFEB2F4Q37730555-81676340-D938-41D5-AD17-662150EAFBD2Q41012621-EE1373DA-0921-478D-AB7D-BC34F0C34032Q43410554-E12B18E0-8E00-430D-9F4C-323CA33F1787Q44572593-344C8D15-0ADB-4E21-86A5-97244FC4413DQ51553464-620DA160-1F0B-45C3-9997-C8915C2329F9Q56899537-55EFD79E-0A8E-42D0-9352-7A4CAA54DEE2Q56901080-B688489E-7580-4E90-83D2-B646766A31C7Q56901479-DFB47153-70D4-4970-A0DC-BCB59841A98DQ56902724-0AE7DCBC-9FB0-4B60-B00D-FA2A2CF376DAQ56902741-FF78163C-56B9-4221-9976-C1CE5BED861CQ56902858-8F07ADBE-5D60-45A7-AAE2-45EB9DB6CE56
P2860
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Detection of circulating solub ...... ndrome and systemic sclerosis.
@en
Detection of circulating solub ...... ndrome and systemic sclerosis.
@nl
type
label
Detection of circulating solub ...... ndrome and systemic sclerosis.
@en
Detection of circulating solub ...... ndrome and systemic sclerosis.
@nl
prefLabel
Detection of circulating solub ...... ndrome and systemic sclerosis.
@en
Detection of circulating solub ...... ndrome and systemic sclerosis.
@nl
P2093
P2860
P1476
Detection of circulating solub ...... ndrome and systemic sclerosis.
@en
P2093
B Devulder
E Hachulla
G Magistrelli
J-Y Bonnefoy
P-Y Hatron
Y Delneste
P2860
P304
P356
10.1111/J.1365-2249.2004.02427.X
P577
2004-05-01T00:00:00Z